140 related articles for article (PubMed ID: 14656364)
1. Effect of montelukast pretreatment on inducible nitric oxide synthase mRNA expression in the lungs of antigen-challenged allergic mice.
Sade K; Schwartz I; Schwartz D; Wolman Y; Chernichovski T; Fireman E; Iaina A; Kivity S
Clin Exp Allergy; 2003 Dec; 33(12):1741-6. PubMed ID: 14656364
[TBL] [Abstract][Full Text] [Related]
2. A leukotriene receptor antagonist modulates iNOS in the lung and in a leukotriene-free cell model.
Offer S; Shoseyov D; Bibi H; Eliraz A; Madar Z
Nitric Oxide; 2003 Aug; 9(1):10-7. PubMed ID: 14559427
[TBL] [Abstract][Full Text] [Related]
3. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
4. Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs.
Leick-Maldonado EA; Kay FU; Leonhardt MC; Kasahara DI; Prado CM; Fernandes FT; Martins MA; Tibério IF
Clin Exp Allergy; 2004 Jan; 34(1):145-52. PubMed ID: 14720275
[TBL] [Abstract][Full Text] [Related]
5. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade.
Henderson WR; Chiang GK; Tien YT; Chi EY
Am J Respir Crit Care Med; 2006 Apr; 173(7):718-28. PubMed ID: 16387808
[TBL] [Abstract][Full Text] [Related]
6. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G
J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
[TBL] [Abstract][Full Text] [Related]
7. [Protective effects of ketamine on allergen-induced airway inflammatory injure and high airway reactivity in asthma: experiment with rats].
Zhu MM; Qian YN; Zhu W; Xu YM; Rong HB; Ding ZN; Fu CZ
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1308-13. PubMed ID: 17727773
[TBL] [Abstract][Full Text] [Related]
8. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma.
Montuschi P; Mondino C; Koch P; Ciabattoni G; Barnes PJ; Baviera G
Chest; 2007 Dec; 132(6):1876-81. PubMed ID: 18079221
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Chest; 2001 Apr; 119(4):1021-6. PubMed ID: 11296164
[TBL] [Abstract][Full Text] [Related]
10. Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma.
Shin IS; Jeon WY; Shin HK; Lee MY
Int Immunopharmacol; 2013 Nov; 17(3):867-73. PubMed ID: 24126112
[TBL] [Abstract][Full Text] [Related]
11. Montelukast exerts no acute direct effect on NO synthases.
Hamacher J; Eichert K; Braun C; Grebe T; Strub A; Lucas R; Eltze M; Wendel A
Pulm Pharmacol Ther; 2007; 20(5):525-33. PubMed ID: 16815057
[TBL] [Abstract][Full Text] [Related]
12. Effect of dexamethasone and Nigella sativa on inducible nitric oxide synthase in the lungs of a murine model of allergic Asthma.
Abdel-Aziz M; Abass A; Zalata K; Abd Al-Galel T; Allam U; Karrouf G
Iran J Allergy Asthma Immunol; 2014 Oct; 13(5):324-34. PubMed ID: 25150073
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene D4 inhalation challenge for predicting short-term efficacy of montelukast: a pilot study.
Guan WJ; Shi X; Zheng JP; Gao Y; Jiang CY; Xie YQ; Liu QX; Zhu Z; Guo E; An JY; Yu XX; Liu WT; Zhong NS
Clin Respir J; 2015 Jan; 9(1):111-20. PubMed ID: 24506412
[TBL] [Abstract][Full Text] [Related]
14. Inducible nitric oxide synthase expression is increased in the alveolar compartment of asthmatic patients.
Tufvesson E; Andersson C; Weidner J; Erjefält JS; Bjermer L
Allergy; 2017 Apr; 72(4):627-635. PubMed ID: 27647044
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone suppresses iNOS yet induces GTPCH and CAT-2 mRNA expression in rat lungs.
Skimming JW; Nasiroglu O; Huang CJ; Wood CE; Stevens BR; Haque IU; Scumpia PO; Sarcia PJ
Am J Physiol Lung Cell Mol Physiol; 2003 Aug; 285(2):L484-91. PubMed ID: 12716655
[TBL] [Abstract][Full Text] [Related]
16. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of inducible nitric oxide synthase from human primary airway epithelial cells.
Donnelly LE; Barnes PJ
Am J Respir Cell Mol Biol; 2002 Jan; 26(1):144-51. PubMed ID: 11751214
[TBL] [Abstract][Full Text] [Related]
18. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old.
Straub DA; Minocchieri S; Moeller A; Hamacher J; Wildhaber JH
Chest; 2005 Feb; 127(2):509-14. PubMed ID: 15705989
[TBL] [Abstract][Full Text] [Related]
19. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast.
Bisgaard H; Loland L; Oj JA
Am J Respir Crit Care Med; 1999 Oct; 160(4):1227-31. PubMed ID: 10508811
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats.
Holma R; Salmenperä P; Riutta A; Virtanen I; Korpela R; Vapaatalo H
Eur J Pharmacol; 2001 Oct; 429(1-3):309-18. PubMed ID: 11698051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
